Answers are grounded in this paper and cite their sources.
Case report shows response to mTOR inhibition in metastatic perivascular epithelioid cell tumor, suggesting potential for treatment.
Perivascular epithelioid cell tumors (PEComa) are a family of rare mesenchymal tumors composed of histologically and immunohistochemically distinctive perivascular epithelioid cells. Female genital tract and retroperitoneum are common sites of origin of PEComa-not otherwise specified. Diagnosis depends upon characteristic morphology and immunohistochemistry findings. Prognosis of unresectable or metastatic disease is poor. Responses to mammalian target of rapamycin (mTOR) inhibition are encouraging but mostly short-lived. We report a case of metastatic PEComa who responded to mTOR inhibition, albeit for a short duration. We also review the existing literature on mTOR inhibitors in PEComa.
No takes yet. Share an insight, caveat, or question.
Ghosh et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: